Oncolys BioPharma News

Oncolys BioPharma: Notice regarding business license applications for manufacturers and sellers of regenerative medicine products

Nov 26 13:00

Oncolys BioPharma: Notice Concerning the Recording of Non-Operating Income and Non-Operating Expenses

Nov 8 12:00

Oncolys BioPharma: Non-consolidated Financial Results for the Nine Months Ended September 30, 2024 [Japanese GAAP]

Nov 8 12:00

Oncolys BioPharma: Summary of financial results for the 3rd quarter of the fiscal year ending 2024/12 [Japanese GAAP] (unconsolidated)

Nov 8 12:00

Oncolys BioPharma: Announcement of the results report on the OBP-601 C9-ALS (amyotrophic lateral sclerosis) Phase2a test in the Annual ALS Research Symposium

Nov 7 07:00

Oncolys BioPharma: Notice regarding monthly exercise status and completion of exercise of the 20th Stock Acquisition Rights (with exercise price amendment clause and exercise suspension clause)

Nov 6 13:30

Oncolys BioPharma: Notice regarding certification of foreign manufacturing sites outsourced to manufacture oncolytic virus OBP-301

Nov 6 11:00

Oncolys BioPharma: Notice regarding the monthly exercise status of the 20th Stock Acquisition Rights (with exercise price correction clauses and suspension of exercise clauses) issued by third party allotment

Nov 1 14:00

Oncolys BioPharma: Notice regarding mass exercise of the 20th Stock Acquisition Rights (with exercise price correction clauses and suspension of exercise clauses) issued by third party allotment

Oct 28 14:00

Oncolys BioPharma: Change Report

Oct 23 09:42

Oncolys BioPharma: Change Report (short-term mass transfer)

Oct 22 14:28

Oncolys BioPharma: Change Report

Oct 21 09:19

Oncolys BioPharma: Notice regarding responses to inquiries

Oct 21 07:00

Oncolys BioPharma: “Stobo IR Conference 2024 in Sapporo Bio-Related Stocks Special” Archived Video Release Notice

Oct 18 15:00

Oncolys BioPharma: Change report.

Oct 18 14:21

Oncolys BioPharma: Notice of presentation on oncolytic virus at the 62nd Annual Meeting of the Japanese Society for Cancer Therapy

Oct 18 11:00

Oncolys BioPharma: Notice regarding mass exercise of the 20th Stock Acquisition Rights (with exercise price correction clauses and suspension of exercise clauses) issued by third party allotment

Oct 17 14:30

Oncolys BioPharma: Notice of co-hosting a luncheon seminar on virus therapy at the 62nd Annual Meeting of the Japanese Society for Cancer Therapy

Oct 17 11:00

Oncolys BioPharma: Announcement of the conference presentation of oncolytic virus OBP-301 at the 62nd Annual Meeting of the Japanese Society for Cancer Therapy

Oct 16 11:00

Oncolys BioPharma: Notice regarding mass exercise of the 20th Stock Acquisition Rights (with exercise price correction clauses and suspension of exercise clauses) issued by third party allotment

Oct 15 15:00